Background: Provitamin A carotenoids are a significant source of dietary vitamin A for many 2
Introduction 30
Provitamin A carotenoids, especially β-carotene, are an important dietary source of vitamin A, 31 especially in low-income countries where vitamin A deficiency remains a public health problem 32
(1). Available data, based mainly on results for β-carotene, indicate that the bioavailability and 33 bioconversion of provitamin A carotenoids to vitamin A [i.e., bioefficacy (2) ] are affected by many 34 factors, including food matrix, preparation methods, genetics, age, etc. (3) . Although several 35 methods have been proposed and used to measure β-carotene bioefficacy (4, 5) , none are ideal 36 for use in the field; in addition, none have been verified by comparison to known reference 37 values. Researchers need a simple, accurate, and feasible method to assess bioefficacy 38 because of β-carotene's contribution to whole-body vitamin A stores and plasma retinol 39 8 Next, we developed a partially-parallel model ( Figure 1B ) that describes trafficking of 106 labeled retinol derived from the conversion of absorbed β-carotene during both absorptive 107 (intestinal) and early plus late post-absorptive (extra-intestinal) phases. A "partially-parallel 108 model" means that we used the same values for kinetic parameters in the model for β-carotene-109 derived retinol as we used in the model for retinyl acetate-derived retinol when we were 110 describing biochemical and physiological processes that one logically assumes to be identical for 111 the two labels. It should be emphasized that this work focuses on retinol derived from the labeled 112 β-carotene dose (i.e., on β-carotene that is converted to retinol and secreted into plasma after 113 conversion). For the absorptive / intestinal pathway ( Figure 1B , unshaded components), the 114 model was parallel to the one in Figure 1A ; that model had been developed (6) for subjects 115 whose data indicated little to no post-absorptive conversion of absorbed β-carotene to retinol. 116
For the post-absorptive / extra-intestinal pathway ( Figure 1B , shaded components), we used 117 aspects of the model presented by Novotny et al. (17) as well as other information in the literature 118 (18) (19) (20) . In Figure 1B , components 11 to 13 represent the processes of digestion and absorption 119 of β-carotene; compartment 11 is the site of splitting of the β-carotene dose into the fraction 120 eventually converted to retinol (that which is transferred to compartment 12) versus that which 121 does not contribute to bioefficacy. Bioefficacy was partitioned into absorptive and post-absorptive 122 components at delay component 13 as follows. For the intestinal bioconversion pathway, 123 absorbed β-carotene is converted to retinol and packaged in chylomicrons, and the retinol 124 (primarily retinyl esters) is transferred to compartment 14. For the post-absorptive pathway, 125 chylomicron β-carotene is transferred from component 13 to compartment 21, which represents 126 tissue uptake (both extrahepatic and hepatic) of β-carotene from chylomicrons or chylomicron 127
remnants. This β-carotene can be converted to retinol in tissues (compartment 24), representing 128 early post-absorptive conversion (solid-line arrow), or it may be delayed by passing from 129 compartment 21 through components 22 we could evaluate the RIR and IRM, we chose ten values for β-carotene relative bioefficacy 139 ranging from 10 to 50%, reflecting the variability reported in the literature (5); then we assigned a 140 value to each subject. Assignments were made based on individual total body vitamin A stores 141 (Supplemental Table 1 ); the results of Green et al. (6) , which indicated that the subjects in that 142 study had little post-absorptive conversion; and the results of Tang et al. (14) , from which we 143 selected the three subjects that were reported to be the lowest, average, and highest converters 144 of β-carotene. Each level of relative bioefficacy was then partitioned into hypothetical but 145 physiologically-reasonable values for absorptive (7 -40%) and post-absorptive (3 -20%) 146 components. For example, for subject 1, we assigned a total relative bioefficacy of 10% and 147 attributed 7% bioefficacy to intestinal bioconversion and 3% to extra-intestinal processes. 148
Additionally, each value for post-absorptive conversion was partitioned into early and late 149 components (e.g., 2.4% early and 0.6% late for subject 1 Figure 1A ). Time points 158 (n=21; 0, 3, 6, 9, and 11 h, then daily for 9 d, and weekly from 14 to 56 d) for the simulation were 159 based on the study of Tang et al. (14) , in which extensive blood sampling had been done to 160 provide the detailed plasma tracer kinetic curves needed for model-based compartmental 161
analysis. 162
Next, to generate corresponding data for β-carotene-derived retinol, we fixed parameters 163 in the model shown in Figure 1B at the values presented in Supplemental Table 1 . These 164 included model parameters described in Supplemental Methods 2 that generated the assigned 165 values for total, absorptive, and post-absorptive (early and late) bioefficacy. Then, data for FD p 166 versus time (3 h to 56 d) were simulated to generate plasma tracer response profiles for retinol 167 derived from the β-carotene dose for each of the ten subjects at the various levels of bioefficacy. 168
For each subject, simulations resulted in plasma data for labeled retinol derived from three 169 sources: the retinyl acetate reference dose, absorptive (intestinal) conversion of β-carotene to 170 retinol, and post-absorptive (extra-intestinal, early and late) conversion of β-carotene to retinol. 171
Datasets for FD p versus time were used to calculate β-carotene relative bioefficacies based on 172 plasma isotope ratios and areas under the curves as described in the next sections. 173
174
Calculation of β-carotene relative bioefficacy from the plasma retinol isotope ratio. Relative 175 bioefficacy was calculated for the datasets described above based on retinol isotope ratios in 176 plasma at specific times using Equation 1: 177 178 RIR relative bioefficacy (%) = (FD p for labeled β-carotene-derived retinol / 179 FD p for labeled retinyl acetate-derived retinol) × 100
(1) 180
11
The plasma RIR was calculated using FD p data in molar retinol activity equivalents (1 µmol β-182 carotene = 2 µmol retinol) at times from 1 to 56 d after dose administration. 183
184
Calculation of β-carotene relative bioefficacy using the isotope reference method. Relative 185 bioefficacy was calculated for the same data using the IRM as applied by Tang et al. (14) and 186 Green et al. (6) (n=30) that had been previously studied by Green et al. (6) . In that paper, relative bioefficacies 205
were calculated using the model-based AUC p method in WinSAAM [i.e., (plasma residence time 206
for β-carotene-derived retinol divided by plasma residence time for retinyl acetate-derived retinol) 207
x 100]. These values were compared in (6) to estimates calculated using the IRM at 14 d; results 208 for the plasma RIR at d 2 were also mentioned in (6) . For the current analysis, relative 209 bioefficacy was calculated using Equations 1 and 2 at 1, 2, 7, and 14 d. 
Plasma isotope response data/curves for the retinol reference dose and for β-carotene-derived 231
retinol. Using the model shown in Figure 1A and the kinetic parameters from Cifelli et al. (15) and 232 Green et al. (6) that are presented in Supplemental Table 1 , we simulated tracer data for plasma 233 13 retinol derived from the retinyl acetate reference dose versus time. As shown in Figures 3A and  234 B (solid lines) for subjects 2 and 8, respectively, plasma retinol tracer peaked ~13 h after dosing 235 and then gradually fell as retinol was distributed to tissues. The bend in the curves at ~7 d 236 indicates recycling of tracer back to plasma. By 10 d post-dosing, the curves entered a terminal 237 slope, equivalent to the apparent system fractional catabolic rate (~3%/d for these two subjects). 238 Similar patterns were observed for the retinyl acetate-derived retinol curves for the other subjects 239
(data not shown). 240
Also presented in Figures 3A and B are the simulated plasma tracer response data for β-241 carotene-derived retinol (dashed lines) when relative bioefficacy was fixed at 14% (10% 242 absorptive and 4% post-absorptive; subject 2) or at 40% (30% absorptive and 10% post-243 absorptive; subject 8). Note that, at the higher (versus lower) level of total β-carotene bioefficacy, 244 the curve for β-carotene-derived retinol is closer to the one for retinol from the reference dose. 245
For all subjects (data not shown), before any late post-absorptive conversion occurred, curves for 246 β-carotene-derived retinol were similar to those for retinyl acetate-derived retinol (i.e., the two 247 curves appeared to be parallel, as illustrated in Figures 3A and B) . At the time set for late post-248 absorptive conversion (delay component 22; Figure 1B ), which was varied from 2 to 5 d across 249 subjects (Supplemental Table 1 ), there was an increased influx of tracer into plasma as newly-250 formed labeled retinol was secreted into compartment 15. At the higher levels of post-absorptive 251 conversion (7 to 20%), the increased input was evident as a discernible hump in the curves for β-252 carotene-derived retinol (as illustrated by the data in Figure 3B ), whereas at the lower levels of 253 post-absorptive conversion (3 to 5%), this influx caused only subtle changes in the curves (as in 254 Figure 3A ). Plasma retinol tracer stabilized after late post-absorptive conversion and the curves 255 entered a terminal slope by ~10 d, becoming parallel to the curve for retinyl acetate-derived 256
retinol. 257
Next, to examine the two components of bioefficacy separately, we used model-based 258 compartmental analysis to simulate the expected plasma isotope response curves for β-carotene14 derived retinol formed from absorptive versus post-absorptive conversion. Figure 4 shows these 260 simulations, along with the curve for retinol derived from the reference dose, for subject 5; see 261 also Supplemental WinSAAM Deck. As was the case for all subjects (data not shown), the 262 curve for absorptive bioconversion (dash-dot line in Figure 4) values for total, absorptive, and post-absorptive relative bioefficacy for the ten subjects ( Table 1) . 277
For all subjects, the plasma RIR accurately predicted known values for total relative bioefficacy 278 from 14 d to the end of the experiment (56 d); specifically, the RIR at either 14 or 56 d predicted a 279 mean of 101% of the known values (range, 100 to 103%). Bioefficacy estimates calculated by 280 the IRM predicted a mean of 92% (range, 74 to 99%) and 95% (range, 84 to 100%) of total 281 bioefficacy at 14 and 56 d, respectively. For 8 of the 10 subjects, the IRM predictions were very 282 close to the known values (96 and 98% of the total at 14 and 56 d, respectively) 283
We then compared the equations' predictions on d 1 to known values for absorptive 284 bioefficacy, as has been done in earlier applications of the IRM when the prediction on 1 d has 285 been said to indicate intestinal bioconversion (14, 22 As shown in Figure 4 inset, at 1 d, the composite curve for β-carotene-derived retinol (dashed 289 line) is higher than the curve for retinol derived from intestinal conversion (dash-dot line). This 290 difference is attributable to a contribution from early post-absorptive conversion (see Discussion) . 291
Note that, when the plasma RIR and IRM were calculated using the appropriate simulated data 292 for retinol derived from intestinal β-carotene conversion and the retinyl acetate reference dose, 293 both methods predicted known values for absorptive bioefficacy at all times from 1 d on (data not 294 shown). When known values for absorptive and early post-absorptive bioefficacy were added 295 together using data in Table 1 To illustrate the changes in relative bioefficacy calculated by the RIR and IRM over time, 305 we present in Figure 5 results for subject 7 who was assigned 35% total relative bioefficacy, 306 partitioned into 28% absorptive and 7% post-absorptive (2.1% early and 4.9% late). For this 307 subject, the plasma RIR at 1 d predicted a relative bioefficacy of 30%, close to the known value 308 for absorptive plus early post-absorptive bioefficacy (30.1%). After late post-absorptive 309 conversion occurred (4.5 d for subject 7) and newly converted retinol derived from β-carotene 310 entered plasma, the RIR was higher (i.e., the numerator in Equation 1 increased), peaking at 6.5 311 d at 48% (138% of the total). The value then fell and stabilized by 14 d at 35.5%, near the known 312 value for total relative bioefficacy (35%). For all subjects, the peak in the RIR occurred between 4 313 and 7 d post-dosing; by 14 d, the RIR stabilized near the known value for total relative bioefficacy. 314
Similar trends versus time were observed for the other subjects (data not shown). These results 315
show that the RIR is highly responsive to late post-absorptive conversion and needs time to 316 stabilize; for these subjects, when late conversion occurred between 2 and 5 d, stabilization in the 317 ratio was evident by 14 d. 318
In the case of the IRM, predictions for subject 7 ( Figure 5 ) gradually increased following 319 late post-absorptive conversion, averaging 92 and 95% of the total bioefficacy at 14 and 56 d, 320
respectively. Similar trends were observed for the other subjects (data not shown). Overall, the 321 IRM predictions at 14 or 56 d were close to the assigned values for total relative bioefficacy, 322 except when there was substantial (late) post-absorptive conversion. Specifically, at the two 323 highest levels of late post-absorptive bioconversion (subjects 6 and 10; 
Comparison of predictions of the plasma RIR and the IRM when applied to previously-published 327
retinol kinetic and bioefficacy data. We applied Equations 1 (RIR) and 2 (IRM) to previously-328 published data (6) for 30 adults for whom bioefficacy had been estimated using WinSAAM. Mean 329 values for relative bioefficacy predicted by the RIR and IRM are plotted over time in Figure 6 . 330
Predictions of the two equations were similar at 1 and 2 d (~12%). For the plasma RIR, 331 predictions were significantly higher on d 7 and d 14 (~15%) compared to d 1 and 2, indicating 332 that some post-absorptive conversion of β-carotene to retinol (~3%) occurred between 2 and 7 d 333 in some of these subjects, even though plasma isotope response curves for subjects in (6) In this paper, we show ( Table 1) feasible to measure β-carotene relative bioefficacy in field settings, where it can be difficult to 356 obtain multiple samples over time, as is done when using the isotope reference method (Equation 357 2) to estimate relative bioefficacy (13) . In addition, the single sample method will facilitate 358 measuring bioefficacy in children, in whom repeated sampling is difficult. It is worth noting that 359 investigators could also assess vitamin A status by collecting an additional blood sample at 4 or 5 360 d and applying an appropriate retinol isotope dilution equation to the retinyl acetate-derived retinol 361 data to predict individual vitamin A total body stores (23) . 362
To our knowledge, this study is the first to evaluate the accuracy of methods for estimating 363 β-carotene relative bioefficacy. We used model-based compartmental analysis (11) and model 364 simulations to verify predictions of known (assigned) values for bioefficacy ( Figure 2) and then 365 applied Equations 1 and 2 to calculate relative bioefficacy using simulated plasma retinol tracer 366 response data. This approach is similar to the one we recently used to test the accuracy of an 367 equation for estimating vitamin A total body stores at isotopic equilibrium (24) . Here, in addition 368 to demonstrating that the plasma RIR accurately predicts β-carotene relative bioefficacy at 14 d 369 or later after dosing, we also showed that the IRM accurately predicts relative bioefficacy for 370 some subjects (specifically, those with low levels of late post-absorptive bioconversion). It would 371 be interesting for other investigators to now apply the RIR retrospectively to their previously-372 collected data from IRM studies to compare results for the two methods. 373
It should be emphasized that both the plasma RIR and IRM estimate bioefficacy relative to 374 the absorption efficiency of the co-administered retinyl acetate reference dose. As methods are 375 developed for measuring vitamin A absorption efficiency, it will be possible to correct estimates of 376 β-carotene relative bioefficacy by including the actual value for absorption efficiency of the 377 reference dose (bioefficacy = relative bioefficacy × reference dose absorption efficiency). 378
In addition to providing a way to evaluate the accuracy of methods for estimating β-379 carotene relative bioefficacy, compartmental modeling also led to insights into the time course 380 and likely pathways for conversion of absorbed β-carotene to retinol. For provitamin A, previous 381 work (14, 17, 22, 25) has suggested that some of the absorbed carotenoid is converted to retinol 382 in the intestine and another portion is converted later (post-absorptive bioconversion) in tissues 383 such as liver and adipose tissue. Starting with these assumptions, the model ( Figure 1B ) 384 developed to generate plasma isotope response data for retinol derived from β-carotene included 385 a site (delay component 13) for partitioning absorbed β-carotene destined for intestinal 386 conversion (compartment 14) or for post-absorptive conversion (compartment 21). We 387 hypothesize that β-carotene in chylomicrons taken up by the liver or extrahepatic tissues could be 388 20 (absorptive plus post-absorptive). This is evident in Figure 3B and can be seen in the results of 414 other investigators (14, 17, 28) . Our data indicate that, after late post-absorptive conversion, the RIR transiently 428 overestimates relative bioefficacy before stabilizing at the correct value for "total" bioefficacy by 429 14 d. Time for ratio stabilization is also required for the plasma dual isotope ratio method used to 430 determine cholesterol absorption (7) and vitamin A absorption (8) . It is interesting to note that, if 431 RIR predictions on d 14 for a given individual are substantially higher than those on d 1, this 432
indicates that late post-absorptive bioconversion is an important contributor to total bioefficacy in 433 that subject. 434
In conclusion, compared to graphical methods (e.g., the isotope reference method), the 435 plasma retinol isotope ratio provides a simpler and more accurate method for estimating 436 carotenoid relative bioefficacy following co-administration of isotope-labeled doses of β-carotene 437 and retinyl acetate (reference dose). The plasma retinol isotope ratio method should be valid for 438 use in both children and adults, and it can be used for test solutions (e.g., isotopes administered 439 in oil) or for intrinsically-labeled carotenoid in foods. The plasma RIR predicts β-carotene relative 440 bioefficacy based on analysis of one blood sample collected 14 d or more after dosing. 441
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